RCKT FY 2015 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$538M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$45,000

Operating Income

-$20M

Net Income

-$68M

EPS (Diluted)

$-14.85

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$113M

Total Liabilities

$5M

Stockholders' Equity

$109M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$45,000	$0	—
Operating Income	-$20M	-$8M	-164.7%
Net Income	-$68M	-$10M	-613.3%